Intradiscal PRP Clinical Study
BACKGROUND: Low back pain is the number one cause of musculoskeletal disability world-wide. Neck pain, although less prevalent than back pain, is attributed to similar causes. Disc degeneration starts with a tear of the annulus fibrosus that can result in acute and chronic pain and progress to disc herniation and degeneration. We have experienced success with disc injections of platelet-rich plasma (PRP) to augment the natural healing response. The technique and rationale can be found in “Platelet Rich Plasma”, editor Lana, publisher Springer, 2014.
CURRENT RESEARCH FINDINGS: As of late May 2017, Dr. Bodor has delivered intradiscal PRP to 208 patients, treating 499 discs – including cervical, thoracic, and lumbar – through a total of 253 procedures. Approximately 75% of patients have experienced good to excellent outcomes in 6 – 8 weeks following the injections. Dr. Bodor and his research team will complete a three-month and a one-year follow up with those who have received PRP treatment for degenerative disc disease.
HYPOTHESIS: We hypothesize that the best outcomes will occur in patients who obtain a positive response to an anesthetic discogram, who have a history of an acute injury to their disc or findings of annular tear and who have lower risk factors for ongoing disc degeneration.
GOAL: We hope to establish the efficacy of similar PRP injection in the cervical spine and will continue to prove the effectiveness on the lumbar and thoracic spine for eventual publication.
Reduce Pain. Increase Mobility + Function. Improve Quality of Life.
All the research conducted through the Napa Medical Research Foundation, a 501(c)(3) nonprofit organization, is fully funded through generous donations received from individuals and family foundations.